谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Supplementary table 3 from A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523) in Metastatic Uveal Melanoma

Elizabeth I. Buchbinder,Justine V. Cohen,Giuseppe Tarantino,Christine G. Lian,David Liu,Rizwan Haq,F. Stephen Hodi,Donald P. Lawrence,Anita Giobbie-Hurder,Deborah Knoerzer,Ryan J. Sullivan

crossref（2024）

引用 0|浏览16
暂无评分
摘要

Supplementary table 3: Adverse Events/toxicities felt to be at least possibly related to drug.

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要